Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Psychedelics

Psychedelics

Group By Ticker
Sort By
Newest | Oldest
Read More
4 minute read
  • Cannabis
  • Contracts
  • Financing
  • Global
  • Guidance
  • Legal
  • Management
  • Markets
  • News
  • Offerings
  • Penny Stocks
  • Psychedelics
  • Small Cap

6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements

By Lara Goldstein
Today, 5:49 AM
Second week of 2023, and business is up and running. Let’s take a look at the announcements shared by some of the companies in the psychedelics space.

BRAXF

Read More
4 minute read
  • Cannabis
  • Financing
  • Global
  • Legal
  • Management
  • Markets
  • News
  • Psychedelics

Psyched: NY Discusses Regulations, MDMA For PTSD Aims For Legalization, Shrooms For Eating Disorders & More

By Lara Goldstein
Today, 5:49 AM
Guess Which East Coast State Is Now Discussing Legalizing Psychedelics? Decriminalizing psychedelics is one thing, but fully legalizing them is another. That's currently a measure before New York's Senate Health Committee.

PSIL

Read More
3 minute read
  • Cannabis
  • Legal
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Where Are Psychedelics Headed In 2023? These Two Heavy Hitters Share Their Plans

By Lara Goldstein
Today, 5:49 AM
It’s the beginning of 2023 and psychedelics companies are updating the public on their developmental and clinical progress as well as their selected milestones for the year.

CYBN

Read More
1 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Small Cap

atai Life Sciences’ Drug Trial For Depression Fails To Deliver Expected Results, Stock Plunges

By Lara Goldstein
Today, 5:49 AM
Clinical-stage psychedelics biotech atai Life Sciences (NASDAQ: ATAI) shared the results of its NYC-based subsidiary NYC-based Perception Neuroscience’s Phase 2a study of proprietary R-ketamine PCN-101 on patients with Treatment-Resistant Depression (TRD.).

ATAI

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

This Original Psychedelic-Based Obesity Treatment Set To First-In-Human Trials

By Lara Goldstein
Today, 5:49 AM
Psychedelics biopharma company Clearmind Medicine Inc. (NASDAQ: CMND) and clinical-stage firm SciSparc Ltd.

CMND

Read More
2 minute read
  • Cannabis
  • FDA
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Treating Binge Eating Disorder With Magic Mushrooms: Phase 2 Clinical Trial Gets Thumbs Up

By Lara Goldstein
Today, 5:49 AM
Clinical-stage psychedelics biotech Tryp Therapeutics, Inc.

TRYPF

Read More
9 minute read
  • Cannabis
  • FDA
  • Legal
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Small Cap

These Are The 11 Biggest Psychedelics News And Trends You May Have Missed Last Year

By Lara Goldstein
Today, 5:49 AM
What a year for psychedelics!

ATAI

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Business & Academia Join Forces To Study Magic Mushroom Therapy For IBS Patients

By Lara Goldstein
Today, 5:49 AM
Psychedelics company Tryp Therapeutics Inc.

TRYPF

Read More
3 minute read
  • Cannabis
  • Financing
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Psychedelic Subsidiaries News: Blackhawk Spins Out Three Companies, Algernon Creates A New One

By Lara Goldstein
Today, 5:49 AM
The psychedelics space is up and running. Together with the start of the new year, two companies have shared their latest financial decisions toward advancing their medical business programs.

AGNPF

Read More
2 minute read
  • Entertainment
  • General
  • Markets
  • Psychedelics

Aubrey Plaza’s Wild Hike In Italy: Taking Mushrooms and Getting Lost With White Lotus Co-Star Meghann Fahy

By Franca Quarneti
Today, 5:49 AM
Aubrey Plaza, the actress who played Harper Spiller in the second season of the critically acclaimed HBO series "The White Lotus," shared a hilarious anecdote from her time filming in Italy.

NFLX

Posts navigation

Previous 1 … 9 10 11 … 47 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service